These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 19213865)

  • 1. European consensus statement on the terminology used in the management of lupus glomerulonephritis.
    Gordon C; Jayne D; Pusey C; Adu D; Amoura Z; Aringer M; Ballerin J; Cervera R; Calvo-Alén J; Chizzolini C; Dayer J; Doria A; Ferrario F; Floege J; Guillevin L; Haubitz M; Hiepe F; Houssiau F; Lesavre P; Lightstone L; Meroni P; Meyer O; Moulin B; O'Reilly K; Praga M; Schulze-Koops H; Sinico R; Smith K; Tincani A; Vasconcelos C; Hughes G
    Lupus; 2009 Mar; 18(3):257-63. PubMed ID: 19213865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lupus nephritis: pathophysiology, diagnosis, and collaborative management.
    Smith DM; Fortune-Faulkner EM; Spurbeck BL
    Nephrol Nurs J; 2000 Apr; 27(2):199-204, 209-11. PubMed ID: 11111547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overview of lupus nephritis management guidelines and perspective from Asia.
    Mok CC; Yap DY; Navarra SV; Liu ZH; Zhao MH; Lu L; Takeuchi T; Avihingsanon Y; Yu XQ; Lapid EA; Lugue-Lizardo LR; Sumethkul V; Shen N; Chen SL; Chan TM;
    Nephrology (Carlton); 2014 Jan; 19(1):11-20. PubMed ID: 23876069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in rituximab use between pediatric rheumatologists and nephrologists for the treatment of refractory lupus nephritis and renal flare in childhood-onset SLE.
    Gilbert M; Goilav B; Hsu JJ; Nietert PJ; Meidan E; Chua A; Ardoin SP; Wenderfer SE; von Scheven E; Ruth NM;
    Pediatr Rheumatol Online J; 2021 Aug; 19(1):137. PubMed ID: 34461932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical trials in systemic lupus erythematosus (SLE): lessons from the past as we proceed to the future--the EULAR recommendations for the management of SLE and the use of end-points in clinical trials.
    Bertsias G; Gordon C; Boumpas DT
    Lupus; 2008 May; 17(5):437-42. PubMed ID: 18490423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Pediatric Rheumatology International Trials Organization/American College of Rheumatology provisional criteria for the evaluation of response to therapy in juvenile systemic lupus erythematosus: prospective validation of the definition of improvement.
    Ruperto N; Ravelli A; Oliveira S; Alessio M; Mihaylova D; Pasic S; Cortis E; Apaz M; Burgos-Vargas R; Kanakoudi-Tsakalidou F; Norambuena X; Corona F; Gerloni V; Hagelberg S; Aggarwal A; Dolezalova P; Saad CM; Bae SC; Vesely R; Avcin T; Foster H; Duarte C; Herlin T; Horneff G; Lepore L; van Rossum M; Trail L; Pistorio A; Andersson-Gäre B; Giannini EH; Martini A;
    Arthritis Rheum; 2006 Jun; 55(3):355-63. PubMed ID: 16739203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and management of refractory lupus nephritis.
    Pons-Estel GJ; Serrano R; Plasín MA; Espinosa G; Cervera R
    Autoimmun Rev; 2011 Sep; 10(11):655-63. PubMed ID: 21565286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis.
    Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; van Houwelingen HC; Derksen RH; Berden JH
    Nephrol Dial Transplant; 2008 Jan; 23(1):223-30. PubMed ID: 17981886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EULAR recommendations for the management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics.
    Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostal C; Font J; Gilboe IM; Houssiau F; Huizinga T; Isenberg D; Kallenberg CG; Khamashta M; Piette JC; Schneider M; Smolen J; Sturfelt G; Tincani A; van Vollenhoven R; Gordon C; Boumpas DT;
    Ann Rheum Dis; 2008 Feb; 67(2):195-205. PubMed ID: 17504841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations.
    Aletaha D; Landewe R; Karonitsch T; Bathon J; Boers M; Bombardier C; Bombardieri S; Choi H; Combe B; Dougados M; Emery P; Gomez-Reino J; Keystone E; Koch G; Kvien TK; Martin-Mola E; Matucci-Cerinic M; Michaud K; O'Dell J; Paulus H; Pincus T; Richards P; Simon L; Siegel J; Smolen JS; Sokka T; Strand V; Tugwell P; van der Heijde D; van Riel P; Vlad S; van Vollenhoven R; Ward M; Weinblatt M; Wells G; White B; Wolfe F; Zhang B; Zink A; Felson D
    Ann Rheum Dis; 2008 Oct; 67(10):1360-4. PubMed ID: 18791055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse proliferative glomerulonephritis does not determine the worst outcome in childhood-onset lupus nephritis: a 23-year experience in a single centre.
    Vachvanichsanong P; Dissaneewate P; McNeil E
    Nephrol Dial Transplant; 2009 Sep; 24(9):2729-34. PubMed ID: 19395731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The Montreal definition and classification of gastroesophageal reflux disease: a global, evidence-based consensus paper].
    Vakil N; van Zanten SV; Kahrilas P; Dent J; Jones R;
    Z Gastroenterol; 2007 Nov; 45(11):1125-40. PubMed ID: 18027314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview of lupus nephritis management guidelines and perspective from Asia.
    Mok CC; Yap DY; Navarra SV; Liu ZH; Zhao MH; Lu L; Takeuchi T; Avihingsanon Y; Yu XQ; Lapid EA; Lugue-Lizardo LR; Sumethkul V; Shen N; Chen SL; Chan TM;
    Int J Rheum Dis; 2013 Dec; 16(6):625-36. PubMed ID: 24382275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus group (EGCCCG): part I.
    Krege S; Beyer J; Souchon R; Albers P; Albrecht W; Algaba F; Bamberg M; Bodrogi I; Bokemeyer C; Cavallin-Ståhl E; Classen J; Clemm C; Cohn-Cedermark G; Culine S; Daugaard G; De Mulder PH; De Santis M; de Wit M; de Wit R; Derigs HG; Dieckmann KP; Dieing A; Droz JP; Fenner M; Fizazi K; Flechon A; Fosså SD; del Muro XG; Gauler T; Geczi L; Gerl A; Germa-Lluch JR; Gillessen S; Hartmann JT; Hartmann M; Heidenreich A; Hoeltl W; Horwich A; Huddart R; Jewett M; Joffe J; Jones WG; Kisbenedek L; Klepp O; Kliesch S; Koehrmann KU; Kollmannsberger C; Kuczyk M; Laguna P; Galvis OL; Loy V; Mason MD; Mead GM; Mueller R; Nichols C; Nicolai N; Oliver T; Ondrus D; Oosterhof GO; Ares LP; Pizzocaro G; Pont J; Pottek T; Powles T; Rick O; Rosti G; Salvioni R; Scheiderbauer J; Schmelz HU; Schmidberger H; Schmoll HJ; Schrader M; Sedlmayer F; Skakkebaek NE; Sohaib A; Tjulandin S; Warde P; Weinknecht S; Weissbach L; Wittekind C; Winter E; Wood L; von der Maase H
    Eur Urol; 2008 Mar; 53(3):478-96. PubMed ID: 18191324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Pediatric Rheumatology European Society/American College of Rheumatology/European League against Rheumatism provisional classification criteria for juvenile systemic sclerosis.
    Zulian F; Woo P; Athreya BH; Laxer RM; Medsger TA; Lehman TJ; Cerinic MM; Martini G; Ravelli A; Russo R; Cuttica R; de Oliveira SK; Denton CP; Cozzi F; Foeldvari I; Ruperto N
    Arthritis Rheum; 2007 Mar; 57(2):203-12. PubMed ID: 17330294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials.
    ; Mikdashi JA; Esdaile JM; Alarcón GS; Crofford L; Fessler BJ; Shanberg L; Brunner H; Gall V; Kalden JR; Lockshin MD; Liang MH; Roberts N; Schneider M
    Lupus; 2007; 16(6):418-25. PubMed ID: 17664232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EULAR points to consider for conducting clinical trials in systemic lupus erythematosus.
    Gordon C; Bertsias G; Ioannidis JP; Boletis J; Bombardieri S; Cervera R; Dostál C; Font J; Gilboe IM; Houssiau F; Huizinga TW; Isenberg D; Kallenberg CG; Khamashta MA; Piette JC; Schneider M; Smolen JS; Sturfelt G; Tincani A; Van Vollenhoven R; Boumpas DT
    Ann Rheum Dis; 2009 Apr; 68(4):470-6. PubMed ID: 18388158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rewriting the histological classification of lupus nephritis.
    Schwartz MM; Lewis EJ
    J Nephrol; 2002; 15 Suppl 6():S11-9. PubMed ID: 12515369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular analysis of HLA-DRB1 allelic associations with systemic lupus erythematous and lupus nephritis in Taiwan.
    Pan CF; Wu CJ; Chen HH; Dang CW; Chang FM; Liu HF; Chu CC; Lin M; Lee YJ
    Lupus; 2009 Jul; 18(8):698-704. PubMed ID: 19502265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. European consensus conference on diagnosis and treatment of germ cell cancer: a report of the second meeting of the European Germ Cell Cancer Consensus Group (EGCCCG): part II.
    Krege S; Beyer J; Souchon R; Albers P; Albrecht W; Algaba F; Bamberg M; Bodrogi I; Bokemeyer C; Cavallin-Ståhl E; Classen J; Clemm C; Cohn-Cedermark G; Culine S; Daugaard G; De Mulder PH; De Santis M; de Wit M; de Wit R; Derigs HG; Dieckmann KP; Dieing A; Droz JP; Fenner M; Fizazi K; Flechon A; Fosså SD; del Muro XG; Gauler T; Geczi L; Gerl A; Germa-Lluch JR; Gillessen S; Hartmann JT; Hartmann M; Heidenreich A; Hoeltl W; Horwich A; Huddart R; Jewett M; Joffe J; Jones WG; Kisbenedek L; Klepp O; Kliesch S; Koehrmann KU; Kollmannsberger C; Kuczyk M; Laguna P; Galvis OL; Loy V; Mason MD; Mead GM; Mueller R; Nichols C; Nicolai N; Oliver T; Ondrus D; Oosterhof GO; Paz-Ares L; Pizzocaro G; Pont J; Pottek T; Powles T; Rick O; Rosti G; Salvioni R; Scheiderbauer J; Schmelz HU; Schmidberger H; Schmoll HJ; Schrader M; Sedlmayer F; Skakkebaek NE; Sohaib A; Tjulandin S; Warde P; Weinknecht S; Weissbach L; Wittekind C; Winter E; Wood L; von der Maase H
    Eur Urol; 2008 Mar; 53(3):497-513. PubMed ID: 18191015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.